Showing results (291-300 of 372) with videos related to
Sort By:
Pageof 38
Genome Biology|July 3, 2002
Physical mapping of genes in somatic cell radiation hybrids by comparative genomic hybridization to cDNA microarraysJohann Y Lin, Jonathan R Pollack, Fan-Li Chou, et al.Genes, Chromosomes & Cancer|August 10, 2006
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancerAnna Bergamaschi, Young H Kim, Pei Wang, et al.Cancer Research|September 19, 2007
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesisJacques Lapointe, Chunde Li, Craig P Giacomini, et al.Blood|August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26aSandrine Sander, Lars Bullinger, Kay Klapproth, et al.JAMA|June 5, 1996
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illnessP J Krause, S R Telford, A Spielman, et al.Journal of General Internal Medicine|March 30, 2026
Language Preference Is Associated with Goals-of-Care Communication and End-of-Life Care in DementiaLauren R Pollack, Lois Downey, Ruth A Engelberg, et al.Oncotarget|April 21, 2017
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancerXue Gong, Zurab Siprashvili, Okyaz Eminaga, et al.Blood|March 1, 2008
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLLars Bullinger, Konstanze Döhner, Raphael Kranz, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosisJacques Lapointe, Young H Kim, Melinda A Miller, et al.Cancer Research|March 11, 2010
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancerYoon-La Choi, Melanie Bocanegra, Mi Jeong Kwon, et al.Pageof 38